Research

Keep pace with the
ever-expanding longevity market

Explore our FREE reports

Explore now

Slide 1 heading text

Read more

Slide 2 heading text

Learn more

Slide 3 heading text

Read more

Welcome to Longevity Technology's Market Intelligence Unit.

Available to read

Disease management to disease modification – removing plaque to undo atherosclerosis:

Atherosclerosis

Targeting the root causes of skin and hair aging:

Advanced Aesthetics

A personalised path to health:

The way forward for longevity

Unlocking the brain's longevity potential:

Longevity Neurotech

Transforming how we see aging:

Biological age diagnostics

Technologies to live long and independently:

Aging in place

Understanding the reality behind the blood plasma hype:

Young blood

Delaying the menopause to increase women’s healthspan:

Ovarian Longevity

Managing senescent cells to drive human longevity:

Senotherapeutics

A new era of medicine and longevity:

Longevity Supplements

The state of longevity:

Annual Report 2021

Coming soon

Cellular Rejuvenation

Tissue Engineering

Mitochondrial Rejuvenation

Longevity Immunity

Animal Longevity

Find us here ...

Subscribe to our newsletter

© Copyright 2022 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY

First Longevity Ltd is an appointed representative of Prospect Capital Ltd which is authorised and regulated by the Financial Conduct Authority.
The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding and knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.